We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Test Diagnoses Bacterial Meningitis Quickly and Accurately

By LabMedica International staff writers
Posted on 30 Apr 2025

Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. More...

Therefore, rapid diagnosis and treatment are critical. However, distinguishing bacterial meningitis from other similar conditions is often challenging for healthcare providers. Currently, it can take a considerable amount of time to diagnose meningitis, which delays the initiation of appropriate treatment. Until now, there have been no reliable diagnostic tests available that could quickly differentiate bacterial meningitis from other conditions. Researchers have now developed a new diagnostic test capable of quickly and accurately diagnosing bacterial meningitis by measuring the CRP protein in cerebrospinal fluid, a protein commonly tested in blood to detect bacterial infections.

Researchers at Amsterdam UMC (Amsterdam, Netherlands) found that the CRP protein in cerebrospinal fluid is a highly reliable indicator of bacterial meningitis. While CRP is often tested in blood to detect bacterial infections, its value in cerebrospinal fluid had not been extensively studied until now. After successful laboratory tests, the researchers demonstrated that the device used to measure CRP in blood is also sensitive enough to measure CRP in cerebrospinal fluid. Since June 2024, this new test has been incorporated into daily practice at Amsterdam UMC. In their latest, published in The Lancet Regional Health Europe, the researchers described how the test was introduced and assessed its effectiveness in a clinical setting.

The results showed that all patients diagnosed with bacterial meningitis had elevated CRP levels in their cerebrospinal fluid, whereas only a few patients without bacterial meningitis showed similar elevations. The test was also proven to be reliable in additional studies conducted with children and patients in Denmark. It is expected that more hospitals will begin to adopt this test, as it can be performed in laboratories with existing equipment. The cost of the test ranges from three to five euros, offering an affordable and accessible solution for diagnosing and treating bacterial meningitis more quickly.

"Any laboratory in which CRP is measured in blood can introduce this test for cerebrospinal fluid tomorrow. We could not have predicted in advance that a new diagnostic test would be used in patients within a year of its discovery," said last author and Amsterdam UMC neurologist, Matthijs Brouwer.


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Gold Member
Latex Test
SLE-Latex Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.